[{"id":"e2de4bae-d52d-43ef-8d92-741aafbfdceb","acronym":"ONO-7018-01","url":"https://clinicaltrials.gov/study/NCT05515406","created_at":"2022-08-25T12:57:15.308Z","updated_at":"2025-02-25T14:02:58.817Z","phase":"Phase 1","brief_title":"A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL","source_id_and_acronym":"NCT05515406 - ONO-7018-01","lead_sponsor":"Ono Pharmaceutical Co. Ltd","biomarkers":" MALT1","pipe":"","alterations":" ","tags":["MALT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CTX-177"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 108","initiation":"Initiation: 02/13/2023","start_date":" 02/13/2023","primary_txt":" Primary completion: 12/01/2027","primary_completion_date":" 12/01/2027","study_txt":" Completion: 12/01/2027","study_completion_date":" 12/01/2027","last_update_posted":"2025-02-19"},{"id":"8247f050-5754-429c-8909-34be0755d772","acronym":"","url":"https://clinicaltrials.gov/study/NCT05929612","created_at":"2023-07-03T16:10:47.991Z","updated_at":"2024-07-02T16:35:22.969Z","phase":"Phase 2","brief_title":"A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma","source_id_and_acronym":"NCT05929612","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" MALT1","pipe":"","alterations":" ","tags":["MALT1"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 07/28/2023","start_date":" 07/28/2023","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2027","study_completion_date":" 12/31/2027","last_update_posted":"2024-01-18"},{"id":"4037fd6a-d1c0-48d3-b661-3f4b222d1e60","acronym":"","url":"https://clinicaltrials.gov/study/NCT02987127","created_at":"2021-01-18T14:41:40.413Z","updated_at":"2024-07-02T16:37:27.171Z","phase":"","brief_title":"Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma","source_id_and_acronym":"NCT02987127","lead_sponsor":"National Taiwan University Hospital","biomarkers":" BIRC3 • MALT1","pipe":"","alterations":" ","tags":["BIRC3 • MALT1"],"overall_status":"Unknown status","enrollment":" Enrollment 21","initiation":"Initiation: 02/01/2016","start_date":" 02/01/2016","primary_txt":" Primary completion: 09/01/2019","primary_completion_date":" 09/01/2019","study_txt":" Completion: 12/01/2019","study_completion_date":" 12/01/2019","last_update_posted":"2016-12-08"}]